CD274 and neoplasm: While previous studies have suggested that some indicators, such as tumor PD-L1 expression level6 and tumor mutational burden7, could potentially serve as predictors for the response to immunotherapy in LUAD8, the practical applicability of these predictions has not been consistently reliable.